New vaccine trial and early results from first human trial of PrEP implant revealed
23 July 2019 (Mexico City, Mexico) – New studies released at the 10th IAS Conference on HIV Science (IAS 2019) place the spotlight on progress that could completely change the HIV prevention landscape. These include advancements in oral pre-exposure prophylaxis (PrEP) delivery, long-acting implants and vaccines..
Continue reading